ESC Professional Premium Access

Association between prognosis and the use of angiotensin-converting enzyme inhibitors and/or angiotensin II receptor blocker in frail patients with heart failure with preserved ejection fraction

Congress Session

About the speakers

Doctor Akihiro Sunaga

Osaka University Graduate School of Medicine, Suita (Japan)
1 follower

Associate Professor Shungo Hikoso

Osaka University Graduate School of Medicine, Osaka (Japan)
2 presentations
1 follower

6 more presentations in this session

Low-dose dopamine improves ventilatory efficiency during exercise in heart failure with preserved ejection fraction through inhibition of tonic activity of peripheral chemoreceptors

Speaker: Mrs K. Kulej-Lyko (Wroclaw, PL)

Thumbnail

Cardiopulmonary response to exercise and heart failure with preserved ejection fraction risk: a comparative analysis of HFA-PEFF and H2FPEF scores

Speaker: Doctor D. Lazzeroni (Florence, IT)

Thumbnail

A clinical and echocardiographic score to differentiate pulmonary hypertension due to heart failure with preserved ejection fraction from idiopathic pulmonary hypertension: the PH-HFPEF score

Speaker: Doctor A. Ballerini (Bologna, IT)

Thumbnail

Longitudinal characterization of clinically relevant haemodynamics in conscious Ossabaw pigs with HFpEF

Speaker: Mr J. Balitzki (Wuppertal, DE)

Thumbnail

A meta-analysis of exercise hemodynamics in heart failure with preserved ejection fraction: the relevance of PAWP/CO slope

Speaker: Doctor C. Baratto (Milan, IT)

Thumbnail

Access the full session

Heart failure with preserved ejection fraction (HFpEF) 1

Speakers: Doctor A. Sunaga, Associate Professor S. Hikoso, Mrs K. Kulej-Lyko, Doctor D. Lazzeroni, Doctor A. Ballerini...
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

This platform is supported by

logo Novo Nordisk